Renovion, Inc

Biotechnology Research • Chapel Hill, North Carolina, United States • 1-10 Employees

Company overview

Headquarters	900 MLK Jr. Blvd, Suite A, Chapel Hill, NC 27514, US
Phone number	+19192407034
Websites	renovion.com mnhtndose.com
NAICS	541714
SIC	283
Keywords	Gene Therapy, Tracheostomy, Lung Transplant, Nebulizer Therapy, Ntm Ling Disease, Non-Cf Bronchiectasis, Non-Cystic Fibrosis Bronchiectasis, Non-Tuberculous Mycobacteria-Lung Disease
Employees	1-10
Socials

Key Contact at Renovion, Inc

Dan Copeland

CEO

Renovion, Inc Email Formats

Renovion, Inc uses 1 email format. The most common is {first initial} (e.g., j@renovion.com), used 100% of the time.

Format	Example	Percentage
{first initial}	j@renovion.com	100%

About Renovion, Inc

Renovion is a clinical-stage company dedicated to advancing therapies that restore lung health. Our product, ARINA·1, has been developed to change the lives of individuals with a lung transplant, non-cystic fibrosis bronchiectasis (NCFBE), non-tuberculous mycobacteria-lung disease (NTM-LD), and Tracheostomy. *Please note that the Renovion Team is NOT hiring at this time.

Renovion, Inc revenue & valuation

Annual revenue	$427,775
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,400,000
Total funding	No funding